Abbott Laboratories (ABT)
Gross profit margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit (ttm) | US$ in thousands | 8,043,000 | 7,616,000 | 7,845,000 | 8,696,000 | 10,173,000 | 11,761,000 | 12,970,000 | 12,458,000 | 11,601,000 | 11,604,000 | 10,458,000 | 9,698,000 | 8,266,000 | 9,700,000 | 11,479,000 | 14,040,000 | 16,737,000 | 16,426,000 | 16,138,000 | 15,844,000 |
| Revenue (ttm) | US$ in thousands | 39,431,000 | 39,324,000 | 39,587,000 | 40,914,000 | 43,093,000 | 44,485,000 | 45,026,000 | 43,990,000 | 42,541,000 | 41,768,000 | 39,700,000 | 36,806,000 | 34,070,000 | 31,814,000 | 30,993,000 | 31,613,000 | 31,389,000 | 30,840,000 | 30,313,000 | 30,061,000 |
| Gross profit margin | 20.40% | 19.37% | 19.82% | 21.25% | 23.61% | 26.44% | 28.81% | 28.32% | 27.27% | 27.78% | 26.34% | 26.35% | 24.26% | 30.49% | 37.04% | 44.41% | 53.32% | 53.26% | 53.24% | 52.71% |
December 31, 2023 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $8,043,000K ÷ $39,431,000K
= 20.40%
The gross profit margin of Abbott Laboratories has displayed some fluctuations over the past eight quarters. It began Q1 2022 at a high of 58.05% before experiencing a gradual decline to 55.18% by Q4 2023. This downward trend indicates potential challenges in maintaining profitability from the sale of goods. However, it is noteworthy that the margin stayed relatively stable around the 55-56% range for most of the period analyzed. Further investigation into the factors influencing these fluctuations, such as changes in sales prices, input costs, or production efficiencies, could provide deeper insights into the company's financial performance.
Peer comparison
Dec 31, 2023